RxDoctor Payments DataLook up a doctor →

Gary Goldenberg

Dermatology · New York, NYNPI 1336295955

Payments from drug & device makers

$575,934in general payments, 2019–2025

Across 1,385 payments — averaging $415.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$119K
  • AbbVie$107K
  • Novartis$71K
  • Sanofi$48K
  • Bristol Myers Squibb$45K
  • Regeneron Healthcare Solutions, Inc.$45K
  • plus $141K from 41 others
$10,500in research payments, 2019–2025

Across 1 payment — averaging $10,500 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Biofrontera Inc.$11K

What the payments were for

  • Consulting fees$64,82312%
  • Speaking & faculty fees$435,08778%
  • Travel & lodging$30,4285%
  • Food & beverage$27,8995%
  • Education$1960%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$575,934 in reported general payments places this provider in the 95th percentile of 1,151 dermatology providers in New York.

See all dermatology providers in New York

Most prescribed under Part D

DrugClaimsCost to plans & patients
Fluorouracil11$646

Paid to pharmacies, not to this prescriber.

Other dermatology in New York

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →